Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915129 · ClinicalTrials.gov registry record · NA
The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals
A NA study, sponsored by Oregon State University.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06915129 is a NA study that has completed, run by Oregon State University. The registered enrollment target is 12 participants.
The verdict
NCT06915129, a NA study, has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study was to identify specific microbes that change with supplementation with galactooligosaccharides-prebiotics that are associated with alleviation of lactose intolerance symptoms in lactose-intolerant human subjects.
Interventions
- DIETARY_SUPPLEMENT Prebiotic galactooligosaccharides (GOS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2021-12-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06915129
The ClinicalTrials.gov registry entry for NCT06915129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon State University, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prebiotic galactooligosaccharides (GOS) is the first listed.
NCT06915129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06915129 about?
NCT06915129 is a clinical study titled "The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals". The purpose of this study was to identify specific microbes that change with supplementation with galactooligosaccharides-prebiotics that are associated with alleviation of lactose intolerance symptoms in lactose-intolerant human subjects.
What is the current status of trial NCT06915129?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-10-25. Estimated completion is 2021-12-06.
What interventions are being tested in trial NCT06915129?
The interventions under investigation include: Prebiotic galactooligosaccharides (GOS) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06915129?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.